within Pharmacolibrary.Drugs.ATC.N;

model N01AH03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.015283333333333335,
    adminDuration  = 600,
    adminMass      = 0.0005,
    adminCount     = 1,
    Vd             = 0.0149,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Sufentanil is a potent synthetic opioid analgesic belonging to the fentanyl class. It is primarily used as an adjunct in anesthesia and for analgesia during surgery in adults and children, especially in situations requiring rapid onset and short duration of action. Sufentanil is approved for medical use and commonly used in hospital settings for pain management and anesthesia.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult individuals, male and female, with intravenous administration; typical values from multiple clinical studies in perioperative settings.</p><h4>References</h4><ol><li><p>Scholz, J, et al., &amp; Schulz, M (1996). Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. <i>Clinical pharmacokinetics</i> 31(4) 275–292. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199631040-00004&quot;>10.2165/00003088-199631040-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8896944/&quot;>https://pubmed.ncbi.nlm.nih.gov/8896944</a></p></li><li><p>Hughes, LM, et al., &amp; Nestor, CC (2023). Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. <i>Anaesthesia</i> 78(5) 620–625. DOI:<a href=&quot;https://doi.org/10.1111/anae.15952&quot;>10.1111/anae.15952</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36562193/&quot;>https://pubmed.ncbi.nlm.nih.gov/36562193</a></p></li><li><p>Hahn, J, et al., &amp; Chang, MJ (2019). Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy. <i>Critical care (London, England)</i> 23(1) 248–None. DOI:<a href=&quot;https://doi.org/10.1186/s13054-019-2508-4&quot;>10.1186/s13054-019-2508-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31288863/&quot;>https://pubmed.ncbi.nlm.nih.gov/31288863</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N01AH03;
